HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,203,176 | +0.5% | 10,400 | -10.7% | 0.01% | +10.0% |
Q2 2023 | $1,197,688 | -81.5% | 11,645 | -80.4% | 0.01% | -83.3% |
Q1 2023 | $6,485,426 | -95.7% | 59,423 | -95.5% | 0.06% | -96.0% |
Q4 2022 | $149,434,710 | +54.3% | 1,313,135 | -16.1% | 1.50% | +44.3% |
Q3 2022 | $96,842,000 | -23.4% | 1,564,746 | -1.2% | 1.04% | -14.2% |
Q2 2022 | $126,375,000 | -25.1% | 1,584,445 | -1.2% | 1.21% | -15.7% |
Q1 2022 | $168,742,000 | -3.1% | 1,603,861 | -0.7% | 1.44% | +8.2% |
Q4 2021 | $174,093,000 | -4.4% | 1,615,559 | -2.8% | 1.33% | -6.7% |
Q3 2021 | $182,067,000 | +13.4% | 1,662,106 | -3.0% | 1.42% | +5.9% |
Q2 2021 | $160,484,000 | -0.8% | 1,713,835 | -2.5% | 1.34% | -8.1% |
Q1 2021 | $161,807,000 | +19.3% | 1,758,012 | -5.1% | 1.46% | +14.4% |
Q4 2020 | $135,580,000 | -7.1% | 1,853,457 | -1.4% | 1.28% | -19.2% |
Q3 2020 | $146,017,000 | +34.4% | 1,879,730 | -3.9% | 1.58% | +22.4% |
Q2 2020 | $108,680,000 | +1444.4% | 1,955,384 | +723.0% | 1.29% | +1107.5% |
Q1 2020 | $7,037,000 | -23.7% | 237,581 | -6.7% | 0.11% | -4.5% |
Q4 2019 | $9,217,000 | +27.5% | 254,624 | -4.1% | 0.11% | +20.4% |
Q3 2019 | $7,231,000 | +7.8% | 265,558 | -4.8% | 0.09% | +9.4% |
Q2 2019 | $6,709,000 | – | 278,846 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |